
Official start of ThermoBreast on 1 January 2023
ThermoBreast, an innovative and non-contact breast cancer detection and patient monitoring system, is set to revolutionize the way breast cancer is detected. Led by ThermoMind
THIS WEBSITE USES COOKIES
We use cookies to personalise content, to provide social media features, and to analyse our traffic. By choosing 'allow all cookies', you consent to our cookies.
To find out more, read our privacy policy and cookie policy.
ThermoBreast, an innovative and non-contact breast cancer detection and patient monitoring system, is set to revolutionize the way breast cancer is detected. Led by ThermoMind
Funded by the European Union and supported by the Swiss State Secretariat for Education, Research and Innovation (SERI). Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency (HADEA). Neither the European Union nor the granting authority can be held responsible for them (grant agreement no. 101096329).